B&G Foods Inc. (BGS) carries a Roarable Rating of D (Sell) with 45/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±12% realized swing band)
FRED Regime × Technicals: 6% of 52W Range • RSI-14 at 43.2 (NEUTRAL RANGE)
Balance-sheet & 10-K footnote risk deducts 14 pts from forensic ceiling
While BGS currently carries a cautious 45/100 (D) rating due to SEC 10-K Forensic Risk (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Consumer Staples with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.84) and Max Pain ($2.37) forces dealer call-delta covering toward $6.70.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.16% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
B&G Foods Inc. (BGS) surged +9.71% to $2.26, trading at 6% of its 52-week range ($1.99 – $6.38). Stretched risk/reward at current multiples (3% return on capital) under elevated 10-year interest-rate pressure.
PARSIPPANY, N.J., October 28, 2026--B&G Foods, Inc. (NYSE: BGS) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.095 per share of common stock. The dividend is payable on J
PARSIPPANY, N.J., October 27, 2026--B&G Foods, Inc. (NYSE: BGS) announced today that it intends to issue a press release with third quarter 2026 financial results after the market close on Tuesday, November 10, 2026. B&G
The fair value estimate for B&G Foods has been cut from US$4.20 to US$3.60, placing it firmly within the cluster of reduced price targets that several research houses now cite in the US$3 to US$4.50 range. This adjustmen
Shareholders of B&G Foods would probably like to forget the past six months even happened. The stock dropped 58.6% and now trades at $2.18. This might have investors contemplating their next move.
Evercore ISI Group analyst David Palmer maintains B&G Foods (NYSE:BGS) with a In-Line and lowers the price target from $4.5 to $3.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -5.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BGS today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BGS. Explore sector supply chains on /butterfly.
Across 146 tracked Consumer Staples securities in the Roarable RQD universe, B&G Foods Inc. (BGS) ranks #108 by composite RQD confidence (45/100, grade D) and #98 by equity capitalization ($183.7M). Within this direct 5-issuer industry benchmark cohort, BGS leads on earnings valuation at N/A trailing P/E, while BGS leads on capital efficiency and profitability with 3.3% ROIC and 21.8% gross margin. MED currently holds the highest overall quantitative score in the immediate peer group at 50/100 (D) compared with BGS at 45/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BGS
ACTIVE
B&G Foods Inc. | D | 45/100 | — | 21.8% | 3.3% | +9.71% | $183.7M | Benchmark Subject |
| MED MEDIFAST INC | D | 50/100 | — | 71.3% | -10.2% | -0.16% | $137.1M | /med-vs-bgs → |
| OTLY Oatly Group AB | D | 49/100 | — | — | — | -6.54% | $255.3M | /otly-vs-bgs → |
| BYND Beyond Meat Inc. | D | 46/100 | — | — | -35.0% | +3.51% | $126.9M | /bynd-vs-bgs → |
| AFRI Forafric Global PLC | E | 21/100 | — | 10.4% | -16.5% | -0.08% | $340.6M | /afri-vs-bgs → |
In its most recent audited fiscal period (FY2025, filed 2026-01-03), B&G Foods Inc. (BGS) reported GAAP revenue of $1.83B (-5.4% vs. FY2024 revenue of $1.93B , and -11.3% cumulative change since FY2023) , GAAP net income of -$43.3M, operating cash flow of $101.4M, and free cash flow of $70.7M (-31.7% YoY). On the balance sheet, BGS closed FY2025 with $2.83B in total assets against $1.95B in total debt (Altman Z-Score: 1.24, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-01-03 | $1.83B | -$43.3M | $101.4M | $70.7M | $2.83B | $1.95B |
| FY2024 (FY) | 2024-12-28 | $1.93B | -$251.3M | $130.9M | $103.7M | $2.99B | $2.01B |
| FY2023 (FY) | 2023-12-30 | $2.06B | -$66.2M | $247.8M | $247.8M | — | — |
As of 2026-11-01, B&G Foods Inc. (NYSE: BGS) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 45/100 at a spot price of $2.26 (+9.71% 1D, market cap $183.7M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 6/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 7/20. Across 146 tracked Consumer Staples issuers, BGS ranks #108 in composite RQD confidence.
Within the Consumer Staples sector (Packaged Foods), BGS carries a Roarable D (45/100 RQD), trailing P/E of N/A, gross margin of 21.8%, and ROIC of 3.3%. By comparison, MED (MEDIFAST INC) holds a D grade (50/100 RQD, P/E N/A, ROIC -10.2%, cap $137.1M) and OTLY (Oatly Group AB) posts a D grade (49/100 RQD, P/E N/A, ROIC —, cap $255.3M). Among the 5-stock peer group, BGS leads on earnings multiple (N/A) while BGS leads on capital efficiency (3.3% ROIC).
Per BGS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-03, CIK 0001278027), B&G Foods Inc. generated $1.83B in revenue (-5.4% YoY), -$43.3M in net income, and $70.7M in free cash flow against $2.83B in total assets and $1.95B in total debt. Key quantitative strengths: Established market leader in Consumer Staples with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
BGS last traded at $2.26 (+9.71% on volume of 2,262,175 shares), positioning the stock -20.42% below its 50-day simple moving average ($2.84) and -44.88% below its 200-day simple moving average ($4.10). Across its 52-week range of $1.99 to $6.38, BGS sits at the 6.2% percentile with a 14-day RSI of 43.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.0% ($1.99 to $2.53).
Why BGS Stock surged +9.71% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (3% return on capital) under elevated 10-year interest-rate pressure.